Skip to main content
Barbara Konkle, MD, Oncology, Seattle, WA, UW Medicine/Harborview Medical Center

BarbaraAKonkleMD

Oncology Seattle, WA

Hematologic Oncology

Professor, Medicine, University of Washington School of Medicine

Are you Dr. Konkle?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 65 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Barbara Konkle, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington, Pennsylvania, and Illinois. She is affiliated with UW Medicine/Harborview Medical Center and UW Medicine/University of Washington Medical Center.

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1984 - 1988
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1979 - 1982
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1979

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2009 - 2026
  • PA State Medical License
    PA State Medical License 1988 - 2010
  • IL State Medical License
    IL State Medical License 1979 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Gene Therapy—a Dream Come True?
    Gene Therapy—a Dream Come True?August 6th, 2020
  • Sangamo and Pfizer Announce Updated Results in Gene Therapy Treatment
    Sangamo and Pfizer Announce Updated Results in Gene Therapy TreatmentDecember 18th, 2019
  • Sangamo Annonce Des Présentations De Données Portant Sur La Thérapie Génique Et Sur La Thérapie Cellulaire Ex Vivo À Base De Gènes Modifiés, Qui Seront Données Au Congrès Annuel De L’American Society of Hematology
    Sangamo Annonce Des Présentations De Données Portant Sur La Thérapie Génique Et Sur La Thérapie Cellulaire Ex Vivo À Base De Gènes Modifiés, Qui Seront Données Au Congrès Annuel De L’American Society of HematologyNovember 7th, 2019
  • Join now to see all

Grant Support

  • Von Willebrand Factor In Sickle Cell Disease PathophysiologyNational Heart, Lung, And Blood Institute2012
  • A Pilot Study Of Lmwh For Post-Partum Prophylaxis In Women At Risk Of Venous ThroNational Heart, Lung, And Blood Institute2011
  • A Cross-Sectional Analysis Of Cardiovascular Disease In The Hemophilia PopulationCenters For Disease Control And Prevention2011
  • Novel Biomarkers Predictive Of Heparin-Induced ThrombocytopeniaNational Heart, Lung, And Blood Institute2009–2010
  • Age Dependent Thrombotic Risk Factors In Heparin-Induced ThrombocytopeniaNational Heart, Lung, And Blood Institute2007–2008
  • Mentored Career Development In Clinical Research In Non-Malignant HematologyNational Heart, Lung, And Blood Institute2006–2008
  • Prevention Of The Complications Of Bleeding Disorders Through HtcsCenters For Disease Control And Prevention2006–2007
  • Transfusion/Hemostasis Clinical Research NetworkNational Heart, Lung, And Blood Institute2002–2007
  • Plasminogen Activator Inhibitor 1 Gene ExpressionNational Heart, Lung, And Blood Institute1994
  • Plasminogen Activator Inhibitor-1 Gene ExpressionNational Heart, Lung, And Blood Institute1990–1993

Hospital Affiliations